Poly Medicure Limited
NSE: POLYMED BSE: POLYMED
Prev Close
1964.7
Open Price
1970
Volume
724,200
Today Low / High
1963 / 2096.9
52 WK Low / High
1821.2 / 3357.8
Range
1,967 - 2,174
Prev Close
1964.15
Open Price
1939.05
Volume
19,885
Today Low / High
1939.05 / 2096.3
52 WK Low / High
1822.65 / 3350
Range
1,967 - 2,174
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 2070.6 (target range: 1,967 - 2,174), reflecting a change of 105.9 (5.39014%). On the BSE, it is listed at 2070.25 (target range: 1,967 - 2,174), showing a change of 106.1 (5.40183%). Both the NSE and BSE data indicate positive movement, suggesting the stock is on an upward trend. This could be an attractive opportunity for investors looking for growth.
Poly Medicure Limited Graph
Poly Medicure Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Poly Medicure Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 2,070.60, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 2,070.25 | 2,090.95 | 1,881.86 - 2,300.05 |
| 2,111.66 | 1,689.32 - 2,533.99 | ||
| 2,132.36 | 1,492.65 - 2,772.06 | ||
| Bearish Scenario | 2,070.25 | 2,049.55 | 1,844.59 - 2,254.50 |
| 2,028.85 | 1,623.08 - 2,434.61 | ||
| 2,008.14 | 1,405.70 - 2,610.59 |
Overview of Poly Medicure Limited
ISIN
INE205C01021
Industry
Medical - Instruments & Supplies
Vol.Avg
156,660
Market Cap
209,805,615,600
Last Dividend
3
Official Website
IPO Date
2011-12-07
DCF Diff
3,235.57
DCF
-1,165
Financial Ratios Every Investor Needs
Stock Dividend of POLYMED
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2024-09-19 | September 19, 24 | 3 | 3 | 2024-09-19 | 2024-10-26 | |
| 2023-09-21 | September 21, 23 | 3 | 3 | 2023-09-21 | 2023-10-28 | |
| 2022-09-16 | September 16, 22 | 2.5 | 2.5 | 2022-09-19 | 2022-10-25 | |
| 2021-09-16 | September 16, 21 | 2.5 | 2.5 | 2021-09-17 | 2021-10-24 | |
| 2020-02-27 | February 27, 20 | 2 | 2 | 2020-02-29 | 2020-03-19 | 2020-02-18 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,669.83 Cr | 554.69 Cr | 1,115.14 Cr | 0.6678 | 24.57 Cr | 0.00 Cr | 447.34 Cr | 338.56 Cr | 34.13 | 453.39 Cr | 0.2027 |
| 2024-03-31 | 1,375.80 Cr | 486.69 Cr | 889.11 Cr | 0.6462 | 18.96 Cr | 248.23 Cr | 618.52 Cr | 258.26 Cr | 26.92 | 418.70 Cr | 0.1877 |
| 2023-03-31 | 1,115.23 Cr | 405.88 Cr | 709.36 Cr | 0.6361 | 17.80 Cr | 17.57 Cr | 208.75 Cr | 179.28 Cr | 18.69 | 300.88 Cr | 0.1608 |
| 2022-03-31 | 916.89 Cr | 433.23 Cr | 483.66 Cr | 0.5275 | 18.77 Cr | 17.16 Cr | 159.62 Cr | 146.51 Cr | 15.28 | 252.41 Cr | 0.1598 |
| 2021-03-31 | 775.04 Cr | 336.46 Cr | 438.57 Cr | 0.5659 | 13.14 Cr | 16.83 Cr | 166.86 Cr | 135.87 Cr | 15.25 | 233.27 Cr | 0.1753 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 151.34 Cr | 3,192.45 Cr | 426.79 Cr | 2,765.6579 Cr | 180.25 Cr | 28.90 Cr | 285.57 Cr | 1,130.20 Cr | 0.00 Cr | 2.95 Cr | 20.51 Cr | 370.1692 Cr |
| 2024-03-31 | 12.05 Cr | 1,858.67 Cr | 388.62 Cr | 1,470.0535 Cr | 174.15 Cr | 162.10 Cr | 221.03 Cr | 888.94 Cr | 0.00 Cr | 0.00 Cr | 27.96 Cr | 351.2415 Cr |
| 2023-03-31 | 7.06 Cr | 1,577.21 Cr | 335.58 Cr | 1,241.6272 Cr | 149.02 Cr | 141.95 Cr | 208.65 Cr | 662.38 Cr | 37.98 Cr | 2.74 Cr | 8.97 Cr | 293.3026 Cr |
| 2022-03-31 | 7.76 Cr | 1,376.83 Cr | 289.35 Cr | 1,087.4814 Cr | 126.71 Cr | 118.95 Cr | 168.36 Cr | 476.97 Cr | 26.37 Cr | 3.53 Cr | 20.42 Cr | 226.6783 Cr |
| 2021-03-31 | 4.95 Cr | 1,223.73 Cr | 258.16 Cr | 965.5705 Cr | 137.43 Cr | 132.47 Cr | 126.48 Cr | 391.02 Cr | 34.69 Cr | 4.33 Cr | 50.86 Cr | 171.3966 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 240.4193 Cr | -1,194.2794 Cr | 950.5058 Cr | -90.6061 Cr | -3.3543 Cr | 8.6988 Cr | -331.0254 Cr | 338.5572 Cr | 8.5854 Cr | -30.3409 Cr | -64.5423 Cr |
| 2024-03-31 | 266.0822 Cr | -240.9380 Cr | -20.1535 Cr | -10.9337 Cr | 4.9907 Cr | 12.0531 Cr | -277.0159 Cr | 258.2597 Cr | 21.1196 Cr | -28.7400 Cr | -12.3756 Cr |
| 2023-03-31 | 190.8262 Cr | -179.0159 Cr | -12.5053 Cr | -48.4486 Cr | -0.6950 Cr | 7.0624 Cr | -239.2748 Cr | 237.4914 Cr | 20.9899 Cr | -23.9730 Cr | -40.2905 Cr |
| 2022-03-31 | 123.4723 Cr | -85.3316 Cr | -35.3379 Cr | -32.1054 Cr | 2.8028 Cr | 7.7574 Cr | -155.5777 Cr | 195.2449 Cr | -6.2816 Cr | -23.9156 Cr | -41.8823 Cr |
| 2021-03-31 | 118.7318 Cr | -435.5830 Cr | 316.9485 Cr | 23.6006 Cr | 0.0972 Cr | 4.9546 Cr | -95.1312 Cr | 180.0540 Cr | -66.4518 Cr | 0.0000 Cr | -14.3871 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 403.21 Cr | 127.23 Cr | 275.98 Cr | 0.6845 | 82.88 Cr | 93.08 Cr | 9.19 | 149.15 Cr | 0.2309 |
| 2025-03-31 | 440.83 Cr | 147.39 Cr | 293.44 Cr | 0.6656 | 120.57 Cr | 91.83 Cr | 8.92 | 119.23 Cr | 0.2083 |
| 2024-12-31 | 424.21 Cr | 146.51 Cr | 277.70 Cr | 0.6546 | 93.04 Cr | 85.23 Cr | 8.48 | 138.06 Cr | 0.2009 |
| 2024-09-30 | 420.02 Cr | 231.46 Cr | 188.55 Cr | 0.4489 | 94.47 Cr | 87.45 Cr | 9.01 | 142.18 Cr | 0.2082 |
| 2024-06-30 | 384.78 Cr | 218.70 Cr | 166.08 Cr | 0.4316 | 84.27 Cr | 74.04 Cr | 7.71 | 103.92 Cr | 0.1924 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 151.34 Cr | 1,056.61 Cr | 1,207.96 Cr | 349.73 Cr | 285.57 Cr | 1,917.00 Cr | 1,130.20 Cr | 3,192.45 Cr | 426.79 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 1,251.29 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -2,591.26 Cr |
| 2024-09-30 | 13.09 Cr | 1,059.17 Cr | 1,251.29 Cr | 328.76 Cr | 269.84 Cr | 1,924.05 Cr | 979.21 Cr | 3,052.26 Cr | 461.00 Cr |
| 2024-06-30 | -286.40 Cr | 572.80 Cr | 286.40 Cr | 0.00 Cr | 0.00 Cr | 286.40 Cr | 0.00 Cr | 0.00 Cr | -1,470.05 Cr |
| 2024-03-31 | 146.86 Cr | 139.54 Cr | 286.40 Cr | 269.94 Cr | 221.03 Cr | 841.63 Cr | 888.94 Cr | 1,858.67 Cr | 385.62 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 91.83 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-12-31 | 85.23 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 87.45 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 74.04 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 68.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| 2017-03-24 | March 24, 17 | 2:1 |
| 2015-02-02 | February 02, 15 | 2:1 |
| 2013-07-09 | July 09, 13 | 2:1 |
Similar Stocks: Medical - Instruments & Supplies
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Poly Medicure Limited | POLYMED | ₹2,070.60 | ₹209,805,615,600.00 | ₹724,200.00 |
| Dr. Agarwal's Health Care Limited | AGARWALEYE | ₹455.65 | ₹144,057,556,734.00 | ₹88,795.00 |
| Shaily Engineering Plastics Limited | SHAILY | ₹2,103.40 | ₹96,661,957,340.00 | ₹463,986.00 |
Key Executives
Gender: male
Year Born: 1968
Gender: male
Year Born: 1967
Gender: male
Year Born: 1971
Gender: male
Year Born: 1972
Gender: male
Year Born: 1967
Gender: male
Year Born: 1942
Gender: male
Year Born:
Gender: male
Year Born: 1959
Gender: male
Year Born: 1972
Gender: male
Year Born: 1974
FAQs about Poly Medicure Limited
The CEO is Himanshu Baid.
The current price is ₹2,070.60.
The range is ₹1821.2-3357.8.
The market capitalization is ₹20,980.56 crores.
The dividend yield is 0.14%.
The P/E ratio is 58.65.
The company operates in the Healthcare sector.
Overview of Poly Medicure Limited (ISIN: INE205C01021) is a leading Medical - Instruments & Supplies in India. With a market capitalization of ₹20,980.56 crores and an average daily volume of 156,660 shares, it operates in the Medical - Instruments & Supplies. The company last declared a dividend of ₹3.